NCT06456489 Pulse Steroid Injection in Refractory Rheumatoid Arthritis
| NCT ID | NCT06456489 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Sohag University |
| Condition | Active Rheumatoid Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 268 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 268 participants in total. It began in 2024-05-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Remission or low disease activity in active rheumatoid arthritis
Eligibility Criteria
Inclusion Criteria: * Refractory rheumatoid arthritis patients Exclusion Criteria: * Other connective tissue diseases * Endocrine diseases such as DM and thyroid disorders
Frequently Asked Questions
Who can join the NCT06456489 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Active Rheumatoid Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06456489 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 268 participants.
Is NCT06456489 currently recruiting?
Yes, NCT06456489 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sohag University to inquire about joining.
Where is the NCT06456489 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06456489 clinical trial?
NCT06456489 is sponsored by Sohag University. The trial plans to enroll 268 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.